FNY Investment Advisers’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Hold	0	–	–	–	758
2023 Q1	–	Hold	0	–	–	–	801
2019 Q1	–	Sell	-194	Closed	-$10K	–	965
2018 Q4	$10K	Sell	194 -606	-76%	-$31.2K	﹤0.01%	426
2018 Q3	$65K	Buy	+800	New	+$65K	0.02%	327